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A sensitive measure of repression
 
esearchers have proposed that 
complex embryonic patterns are 
generated by multiple enhancers that 
respond differentially to gradients of 
repressor proteins. In a recent report, 
Dorothy Clyde, Dmitri Papatsenko, 
Stephen Small, and colleagues (New 
York University, New York, NY) 
combine genetics and bioinformatics 
to demonstrate that this model may 
be essentially correct.
The pattern of the fly embryo is 
influenced by combinations of enhancers 
and repressors that control expression 
of the pair rule gene 
 
eve
 
 in seven stripes 
along the anterior–posterior axis, which 
foreshadow the segmented body plan 
of the adult fly. Two enhancers, eve 
3
 
 
 
7 and eve 4
 
 
 
6, control two stripes 
each. Ectopic expression of one of two 
repressor proteins that normally occur 
in opposing gradients, hunchback (Hb) 
or knirps (Kni), uniquely alters 
 
eve
 
 
expression in different stripes. Thus, 
the enhancers respond differently to the 
same concentration of the repressors.
Using computational approaches to 
analyze the Kni and Hb binding sites in 
the two enhancers, Clyde et al. found 
R
 
Repopulating glioma cell lines
 
ancer therapies target rapidly dividing cells, which is a problem 
if tumors contain slow-growing undifferentiated cells that 
act as stem cell for the malignancy, as accumulating evidence 
suggests. Now, Toru Kondo, Takao Setoguchi, and Tetsuya Taga 
C
 
(Kumamoto University, Japan, and University 
of Cambridge, Cambridge, UK) show that this 
problem may be widespread. They find that 
several cancer cell lines maintain a small proportion 
of self-renewing cells.
To search for these potentially dangerous cells, 
Kondo’s team tested several cancer cell lines for 
the presence of side populations (SP) of cells 
containing the breast cancer–resistant protein 1 
(BCRP1), an ATP-dependent transporter 
found in many stem cells. Of six lines tested, 
four had BCRP1-containing SP cells that 
A small proportion of 
tumor cells have stem 
cell–like qualities (boxed).
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accounted for between 0.4% and 2.1% of the total population.
The growth of SP cells requires basic fibroblast growth factor 
(bFGF) and platelet-derived growth factor (PDGF). “bFGF 
seems to be essential for the self-renewal of C6 stem cell but is not 
 
that both the number of sites and the 
predicted binding strength varied between 
the two regulatory regions in a manner 
that correlated with the genetic results. 
Using a position weight matrix that 
evaluates the relative value of having a 
particular nucleotide in a specific site 
within a Kni or Hb binding site, the team 
was able to make detailed predictions of 
how an alteration would modify the bind-
ing affinity. To test whether the predicted 
binding strengths reflect biology, they 
mutated six out of 12 Kni binding sites 
in the eve 3
 
 
 
7 region, lowering their 
predicted affinity such that the mutant 
enhancer should have an intermediary 
affinity for Kni, relative to wild-type 
 
eve
 
 
3
 
 
 
7 and 
 
eve
 
 4
 
 
 
6. As expected, the 
mutant enhancer had an intermediate 
response to a given concentration of Kni.
“We changed a few of these binding 
sites and we changed what we think is 
the binding strength of the enhancer,” 
says Small. “That has really never been 
shown before. It opens up the real 
possibility that we can design more 
intelligent experiments to test how these 
enhancers work—and that we can predict 
the activities of DNA sequences just by 
using the computer.” It also demonstrates 
the possibility of using such cluster 
analysis to locate previously unidentified 
regulatory regions in the genome, 
which Small calls a Holy Grail of 
genomics. 
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Local increases in Kni disrupt individual 
stripes differently.
S
m
a
l
l
/
M
a
c
m
i
l
l
a
n
 
enough to induce stem cell proliferation” says Kondo. In the 
presence of both growth factors, the SP cells proliferate but maintain 
their stem cell–like qualities.
When the authors isolated SP cells and allowed them to repopulate 
a culture, they found that the cells produce both SP 
and non-SP cells. By contrast, non-SP cells cannot 
be induced to take on SP traits, suggesting that the 
SP cells are the population’s stem cells.
It is these SP cells that seem to be responsible for 
malignancy. SP cells injected into immunologically 
compromised mice generate aggressive, invasive 
cancers, whereas non-SP cells generally give rise only 
to local tumors. Since both cell types contain the 
same oncogenic mutations, the difference is probably 
due to epigenetic differences such as silencing, says 
Kondo. He and others are already looking for possible 
stem cell behavior switches, such as Bmi-1, an epigenetic factor 
recently shown to be concentrated in stem cells.
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